Relief Therapeutics (OTC: RLFT.F)
$1.45
(0.0%)
$0.00
Price as of April 24, 2024, 11:18 a.m. ET
Relief Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Relief Therapeutics Company Info
RELIEF THERAPEUTICS Holding AG is a is a commercial-stage biopharmaceutical company, which engages in the research, development, and commercialization of treatment for rare debilitating conditions. The firm offers Physiomimic and TEHCLO, drug delivery platform technologies and a targeted clinical development pipeline consisting of risk-mitigated assets to address rare metabolic disorders, rare skin diseases, and rare respiratory diseases. It also commercializes several legacy products via licensing and distribution partners. The company was founded in 2013 and is headquartered in Geneva, Switzerland.
News & Analysis
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.